1.Osteopontin activates the PI3K/AKT pathway by upregulating LGALS3BP in promotion of hepatoma cell migration
Linlin DENG ; Riwen AN ; Fangxin ZHAO ; Ting LIN ; Cuihua LIU ; Mei HONG ; Jianqiang WU ; Xuan ZHANG
Chinese Journal of Comparative Medicine 2024;34(2):9-15
Objective To investigate the effect and mechanism of osteopontin(OPN)in hepatoma cell migration through galectin-3 binding protein(LGALS3BP).Methods Human hepatoma cell lines SMMC-7721,SMMC-P(stably transfected with empty eukaryotic expression vectors),and SMMC-OPN(stably transfected with the OPN gene)were cultured.mRNA expression levels of OPN and LGALS3BP were measured by RT-qPCR.Western blot assays were used to analyze the relative protein expression of OPN and LGALS3BP and PI3K/AKT pathway.Wound healing assays were performed to explore the cell migration ability.After transfection with LGALS3BP-targeting small interfering RNA(si-LGALS3BP)or negative control small RNA(si-NC)into SMMC-OPN cells,cell migration and relative expression of PI3K/AKT pathway-related proteins were assessed.Results Compared with SMMC-7721 and SMMC-P,the migratory ability of SMMC-OPN cells was significantly reinforced,and expression of LGALS3BP was obviously upregulated at both mRNA and protein levels.Moreover,relative expression of p-PI3K/PI3K and p-AKT/AKT proteins was significantly increased.Wound healing assays showed that the si-LGALS3BP obviously suppressed the migratory ability of SMMC-OPN cells.Furthermore,relative expression of p-PI3K/PI3K and p-AKT/AKT proteins in SMMC-OPN cells was significantly decreased after transfection of si-LGALS3BP.Conclusions OPN activates the PI3K/AKT pathway by upregulating LGALS3BP expression to promote hepatoma cell migration.
2.Regulatory effect of liraglutide on hypoglycemia in patients with type 1 diabetes mellitus:a meta-analysis
Yan WANG ; Fangxin JIN ; Minne LI ; Rujiang LI ; Xueli ZHANG
China Pharmacy 2024;35(23):2908-2914
OBJECTIVE To systematically evaluate the regulatory effect of liraglutide on hypoglycemia in patients with type 1 diabetes mellitus (T1DM) and provide evidence for the prevention and control of hypoglycemia in the clinical treatment of T1DM. METHODS Electronic databases including The Cochrane Library, PubMed, Embase, Web of Science, China Biology Medicine Disc (CBM), CNKI, Wanfang database, and VIP database were searched from the inception of the databases to June 30, 2023. The clinical randomized controlled trials (RCTs) of liraglutide on hypoglycemia in T1DM patients were screened according to inclusion and exclusion criteria. Data extraction, grouping, and subgroup meta-analysis were conducted for the included studies. RESULTS A total of 11 RCTs involving 1 685 patients were ultimately included. Meta-analysis results showed that treatment with 1.2 mg liraglutide could reduce the frequency of hypoglycemia in patients with T1DM [OR=0.81, 95%CI (0.74, 0.88), P<0.01], while treatment with 1.8 mg liraglutide could increase the frequency of hypoglycemia [OR=1.33, 95%CI (1.23, 1.44), P<0.01]. The effect of liraglutide on hypoglycemia in patients with T1DM was not correlated with the duration of hypoglycemia [MD= -0.29, 95%CI (-1.21, 0.63), P=0.53], and did not increase the incidence of severe hypoglycemia in these patients [OR=0.87, 95%CI (0.57, 1.33), P=0.53]. Liraglutide could reduce the levels of glycated hemoglobin [MD=-1.39, 95%CI (-2.65, -0.13), P=0.03], weight [MD=-4.28, 95%CI (-5.01, -3.55), P<0.01], and body mass index [MD=-1.20, 95%CI (-1.80, -0.60), P<0.01] in them. CONCLUSIONS Liraglutide has a bidirectional regulatory effect on hypoglycemia in patients with T1DM, which is correlated with the dose of liraglutide. An appropriate dose of liraglutide (1.2 mg) can inhibit hypoglycemia in these patients, while an increased dose of liraglutide (1.8 mg) can promote hypoglycemia in them.
3.Reversible cerebral vasoconstriction syndrome characterized by postpartum headache: a case report
Xiaowen ZHANG ; Ying ZHOU ; Lina ZHANG ; Fangxin SHI
Chinese Journal of Perinatal Medicine 2022;25(3):215-217
We report the diagnosis and treatment of a case of reversible cerebral vasoconstriction syndrome characterized by postpartum thunderclap headache. The patient experienced a thunderclap headache on the second day after delivery, which gradually worsened. On postpartum day 4, she presented with sudden convulsion and hypertension on admission on May 19, 2020, and was initially diagnosed with postpartum eclampsia. We confirmed the diagnosis of reversible cerebral vasoconstriction syndrome based on the results of cranial magnetic resonance angiography (MRA) and other examinations and the consultation with neurologists. After antihypertensive and spasmolytic treatment, the patient's blood pressure returned to normal, and she was discharged on postpartum day 8. Reexamination with cranial MRA at 50 + days after delivery indicated that the cerebral vasospasm was relieved. No severe headaches or convulsions were observed during follow-up till June 2021.
4.Progress in diagnosis and treatment of pregnancy with Marfan syndrome
Chinese Journal of Perinatal Medicine 2021;24(3):233-236
Pregnancy complicated by Marfan syndrome (MFS) could increase adverse pregnancy outcomes. The most serious MFS-induced complication is aortic dissection (AoD), which could endanger both the mother and the fetus. This article summarizes the research progress in China and overseas in the diagnosis and treatment of pregnancy complicated by MFS in recent years in order to raise awareness and improve prenatal diagnosis and pre-conception counseling, thereby facilitating early diagnosis and timely perinatal multi-disciplinary standardized treatment with a view to improving the prognosis.
5. Apoptosis and expression of apoptotic factors caspase-3, fas and p53 in lumbar ligamentum flavum
Chinese Journal of Tissue Engineering Research 2020;24(8):1195-1199
BACKGROUND: Lumbar spinal stenosis is one of the key causes of gait disorder and low back pain in the older adults. Hypertrophy of the ligamentum flavum is the main pathological mechanism leading to lumbar spinal stenosis. Although there are numerous imaging and pathological studies on the ligamentum flavum, little is reported on cell apoptosis. OBJECTIVE: To detect the apoptotic rate and the expression of caspase-3, fas and p53 in the hypertrophic ligamentum flavum, providing experimental evidence for understanding the mechanism underlying degeneration of the ligamentum flavum. METHODS: In experimental group, 50 hypertrophic ligamentum flavum specimens (L2-S1) confirmed by MRI and postoperative measurement were obtained from 50 patients with lumbar spinal stenosis who underwent posterior decompression surgery. There were 22 males and 28 females, aged from 32 to 74 years old, with an average of 54.46 years old. In control group, 30 non-hypertrophic ligamentum flavum specimens (L2-S1) confirmed by MRI and postoperative measurement were obtained from 30 patients with lumbar disc herniation undergoing surgery and lumbar burst fractures. There were 19 males and 11 females, aged 19-67 years, with an average of 47.27 years old. The apoptotic rate in the ligamentum flavum was detected by TUNEL staining, and the expression of caspase-3, fas and p53 was detected by SP immunohistochemistry. The study protocol was approved by the Ethics Committee of the Sixth Affiliated Hospital of Xinjiang Medical University, with approval No. LFYLLSJ2016007. RESULTS AND CONCLUSION: TUNEL results showed that the average apoptotic rate of the experimental group was (37.80±3.04)%, which was significantly higher than that of the control group [(13.18±1.34)%; t=41.83, P < 0.001]. The immunohistochemical staining of SP revealed that the positive expression percentages of caspase-3, fas and p53 in the ligamentum flavum were all 100% in the experimental group, while the positive percentages were 13.3%, 16.7%, and 10% in the control group, respectively. There was a significant difference between the two groups (P < 0.001). These findings indicate that cell apoptosis in the hypertrophic ligamentum flavum is increased and has a certain correlation with the up-regulation of caspase-3, fas and p53.
6.Progress of Research on Intestinal Mucosal Injury Induced by Acute Exposure to High Altitude
Xiaoli PAN ; Fangxin ZHANG ; Yubao HE ; Lulu HU
Chinese Journal of Gastroenterology 2018;23(4):251-253
High altitude environment is a special ecological environmental system. The specificity of this environment is the main reason of gastrointestinal reaction caused by acute exposure to high altitude. With the development of economy, more and more people come to the plateau,and gastrointestinal reaction caused by acute exposure to high altitude has attracted wide attention by scholars. This article briefly reviewed the mechanism of intestinal mucosal injury induced by acute exposure to high altitude.
7.Challenge and present status of fecal microbiota transplantation in the treatment of ulcerative colitis
Lulu HU ; Binbin WANG ; Fangxin ZHANG
Chinese Journal of Postgraduates of Medicine 2017;40(3):285-288
Ulcerative colitis (UC) is a subtype of inflammatory bowel disease. Its pathogenesis is not clear and the pathogenesis is complex. Moreover, it is recurrent and its healing is delayed. It is a kind of refractory disease. Its incidence and recurrence rate showed a trend of increasing year by year in our country at present. At the present stage, the main treatment focuses on glucocorticoids, aminosalicylic acid, immunosuppressor and biological agent. Although biological agent can greatly improve the efficacy, there are many problems in clinical treatment for a small amount of refractory patients. The comprehensive intervention combined with non-drug treatment should be performed, so as to achieve the curative effect. Fecal microbiota transplantation (FMT) has attracted people′s attention in recent years. It displays a certain therapeutic effect on the treatment of UC in the active stage, especially refractory recurrent UC. Therefore, the domestic and overseas FMT treatment are summarized in the paper.
8.Research progress on mechanism of autophagy in intestinal mucosal barrier function
Binbin WANG ; Chengfeng WU ; Fangxin ZHANG
Basic & Clinical Medicine 2017;37(3):405-409
Autophagy is a biological process in which cells maintain homeostasis through degradation of cytoplasmic macromolecules and damaged organelles by membrane vesicle structure .Autophagy plays a critical role in maintai-ning survival of intestinal epithelial cells during intestinal mucosal barrier dysfunction .A negative regulator of auto-phagy may lead to intestinal inflammation and tumorigenesis .
9.Study on the psychological health and related influencing factors of military nurses who take part in the Tibetan hospital supporting operation
Xiufeng WANG ; Yanli PENG ; Jiucong ZHANG ; Dehua KONG ; Yanli ZHU ; Sasha GE ; Xiaoyi ZHANG ; Fangxin ZHANG
Chinese Journal of Modern Nursing 2017;23(7):909-911
Objective To study on the psychological health and related influencing factors of military nurses who take part in the Tibetan hospital supporting operation.Methods Symptom checklist 90 (SCL-90), coping style questionnaire and personal evaluation questionnaire were employed in the survey of 75 military nurses who took part in the Tibetan hospital supporting operation.Results The scores of Tibetan hospital nurses in high altitude areas were significantly higher than normal person and soldiers in each factors of SCL-90. The correlation analysis showed that the coping factor of problem resolving in coping style had negative relationship with fear factor in SCL-90 (r=-0.231,P<0.01). Remorse factor had positive correlation with all factors of SCL-90 (r=0.301-0.432;P<0.01),while the total score of personal evalation had negatively related to all factors of SCL-90 (r=-0.308--0.423;P<0.01).Conclusions The military nurses who take part in the Tibetan hospital supporting operation are in a poor mental state which is greatly influenced by the coping style and personal evaluation.
10.Palliative primary tumor resection provides survival benefits for the patients with metastatic colorectal cancer and low circulating levels of dehydrogenase and carcinoembryonic antigen
He WENZHUO ; Rong YUMING ; Jiang CHANG ; Liao FANGXIN ; Yin CHENXI ; Guo GUIFANG ; Qiu HUIJUAN ; Zhang BEI ; Xia LIANGPING
Chinese Journal of Cancer 2016;35(9):468-475
Background: It remains controversial whether palliative primary tumor resection (PPTR) can provide survival benefits to the patients with metastatic colorectal cancer (mCRC) who have unresectable metastases. The aim of this study was to evaluate whether PPTR could improve the survival of patients with mCRC. Methods: We conducted a retrospective study on consecutive mCRC patients with unresectable metastases who were diagnosed at Sun Yat?sen University Cancer Center in Guangzhou, Guangdong, China, between January 2005 and December 2012. Overall survival (OS) and progression?free survival (PFS) after first?line chemotherapy failure were compared between the PPTR and non?PPTR patient groups. Results: A total of 387 patients were identified, including 254 who underwent PPTR and 133 who did not. The median OS of the PPTR and non?PPTR groups was 20.8 and 14.8 months (P < 0.001), respectively. The median PFS after first?line chemotherapy was 7.3 and 4.8 months (P < 0.001) in the PPTR and non?PPTR groups, respectively. A larger proportion of patients in the PPTR group (219 of 254, 86.2%) showed local progression compared with that of patients in the non?PPTR group (95 of 133, 71.4%; P < 0.001). Only patients with normal lactate dehydrogenase (LDH) levels and with carcinoembryonic antigen (CEA) levels <70 ng/mL benefited from PPTR (median OS, 22.2 months for the PPTR group and 16.2 months for the non?PPTR group; P < 0.001). Conclusions: For mCRC patients with unresectable metastases, PPTR can improve OS and PFS after first?line chemo?therapy and decrease the incidence of new organ involvement. However, PPTR should be recommended only for patients with normal LDH levels and with CEA levels <70 ng/mL.

Result Analysis
Print
Save
E-mail